Acceptance Rate


Time from acceptance to publication

25 days*

Impact Factor




Total content views in 2020


Total Altmetric mentions in 2020


Aims and scope

BMJ Open Diabetes Research & Care is an open access diabetes journal committed to publishing high-quality basic and clinical research articles regarding type 1 and type 2 diabetes and associated symptoms, complications, and treatments. Submissions are subject to rigorous external peer review to ensure the publication of high-quality information.

The online-only format allows for continuous updates and serves as an invaluable resource to the multidisciplinary community of endocrinology, public health/prevention and internal medicine. A rapid review process will also ensure that timely, up-to-date research is available internationally.

BMJ Open Diabetes Research & Care is published by BMJ in partnership with the American Diabetes Association.

Editorial board

For information about BMJ Open Diabetes Research & Care Editor-in-Chief Mandeep Bajaj and his editorial team, please refer to the Editorial Board page.


BMJ Open Diabetes Research & Care is owned by BMJ.

Journal information

Publication Model Open access
Frequency Continuous
ISSN 2052-4897
Launch Date 2014
Digital Archives Portico, LOCKSS
Indexed by Web of Science Core Collection: Science Citation Index Expanded, Emerging Sources Citation Index; MEDLINE (Index Medicus), PubMed Central, Scopus, Embase (Excerpta Media), DOAJ, Google Scholar
Peer Review Model Single blind; the names of reviewers are hidden from the author

Journal Statistics (2020)

Acceptance rate: 39%

Time to first decision: 30 days (mean)
Time from acceptance to publication: 25 days (mean)

Impact Factor category: Endocrinology & Metabolism
Impact Factor (JCR): 3.388
Impact Factor rank (JCR): 92/145
5 Year Impact Factor:3.98
Journal Citation Indicator:0.77
Eigenfactor Score: 0.00499
Citescore: 3.3
Citescore rank: 121/219
Scimago Journal Rank: 1.347

2020 total content views: 344,410
2020 total Altmetric mentions: 5,263

The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.

How we get these metrics


Online advertising – USA and Canada only

Jim Cunningham
Tel: +1 201.767.4170
Fax: +1 201.767.8065

Online advertising – All countries except USA and Canada


Founded in 1940, the American Diabetes Association funds research to prevent, cure and manage diabetes, and among its many activities delivers services to hundreds of communicates and advocates on behalf of those affected by the disease. www.diabetes.org

Dryad is an international repository of data underlying peer-reviewed articles in the basic and applied biosciences. Dryad enables scientists to validate published findings, explore new analysis methodologies, repurpose data for research questions unanticipated by the original authors, and perform synthetic studies. BMJ has been working with Dryad since 2010.

The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.

The mission of OASPA is to support and represent the interests of open access journal publishers globally in all scientific, technical, and scholarly disciplines. BMJ has been a member since 2009.

All BMJ Open Diabetes Research & Care articles are licensed using either Creative Commons Attribution (CC BY) or Attribution Non-Commercial (CC BY-NC) licence. These licenses let others distribute, remix, tweak and build upon your work. See our open access page for more details.

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results.